Viewing Study NCT02634151


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2026-02-22 @ 9:04 AM
Study NCT ID: NCT02634151
Status: COMPLETED
Last Update Posted: 2020-06-25
First Post: 2015-12-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins
Sponsor: NeuroBo Pharmaceuticals Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: GEM-301
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators